Introducing "VascularCell", an open access medical journal endorsed by
The Australasian Immunohistochemistry Society.
 

Home

 

Welcome to the Australasian Immunohistochemistry Society

Glenn FrancisDear Colleagues,

The Australasian Immunohistochemistry Society (AIS) was created in 2011 to facilitate the exchange of information and “know-how” between professionals working and this field. The official registration of the Society took place immediately after the First International Workshop in Diagnostic Immunohistochemistry which was held in February 2011 in Surfers Paradise, Gold Coast in collaboration with NordiQC. More than 200 people attended this first meeting and since then our Society organises regular workshops which are very popular for both our colleagues and industry partners.
At the present time, one of the most important purposes of the Australasian Immunohistochemistry Society (AIS) is to offer its members the best practical teaching materials which would enable them to be efficient as scientists and pathologists working in the dynamic field of Immunohistochemistry. We aim to advance knowledge in this field by collaborative work of experts which subsequently will have a significant positive impact on the actual histopathological diagnosis and clinical management. Currently, our Society has numerous members from clinical, research and educational institutions based in Australia, New Zealand as well as other parts of the world including Asia, Europe and North America.
Therefore, I encourage you to join our Society and I am sure that we will provide you with the best educational information as well as networking opportunities.

Best wishes,

Professor Glenn Francis

Menzies Health Institute of Queensland, Griffith University, Gold Coast
Genomics For Life, Brisbane
Australia


qdp_aaihc

The Quantitative Digital Pathology-Immunohistochesmitry

(QDP-IHC) section at Menzies Health Institute of Queensland-Griffith University, under the leadership of Dr Eugen Petcu offers for those interested free quantitative digital immunohistochesmtry evaluations for all the nuclear and membranous IHC markers including Her-2 Neu and PDL1-PD1. This service is made possible by the latest technology in the field, GenASIs software which is approved in Australia by TGA (www.metagene.com.au).

Please note that at the present time, QDP-IHC is a research method which aims to inform only the pathologists bearing the histopathological and immunohistochemical diagnosis responsability. QDP-IHC is not an initial diagnostic method.

Read more about QDP from the following resources:
Quantitative Digital Pathology resources

For more information and for QDP-IHC evaluation requests please contact:

Dr Eugen Petcu, MD, PhD
Griffith University School of Medicine
Menzies Health Institute Queensland
Gold Coast Campus, G40, Parklands Drive,
Griffith University, QLD 4222, Australia
tel: 61 7 5678 0761/ 61 4 1029 5981

[email protected]​e


Endorsements

The Australasian Immunohistochemistry Society (AIS) (http://aaihc.org.au/) fully endorses Vascular Cell. The Australasian Immunohistochemistry Society (AIS) represents a hub of knowledge aiming to advance knowledge by the collaborative effort of experts from all areas of biomedical sciences and histopathology with interest in diagnostic and research immunohistochemistry. The Australasian Immunohistochemistry Society (AIS) supports the progress in the filed through its regular international workshops and scientific meetings (http://dihc.org.au/).

Members of The Australasian Immunohistochemistry Society (AIS) will receive a 10% discount on Vascular Cell’s article-processing charge when they provide a discount code (which members can obtain by emailing the Australasian Immunohistochemistry Society) during the submission process.